Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Large Blend · DWS (Xtrackers)

DWS CROCI U.S. Fund Class C (DCUCX)

Ticker DCUCX · Since 2015-04-10 · · Holdings as of Jun 30, 2026

Expense ratio
1.81%$181/yr per $10k
Net assets
$751.1Mall share classes
Holdings
89

Bottom line

Is DCUCX a good fund? The bottom line

DCUCX is the Class C share class of DWS CROCI U.S. Fund, a managed large blend mutual fund from DWS (Xtrackers).

It charges 1.81% — about $181 a year on every $10,000 invested, more expensive than 90% of large blend funds we track.

With $751 million in net assets and 89 holdings, its largest position is Micron Technology Inc (6.9%) and the top 10 make up 31.2% of the portfolio.

What stands out

  • No front-end sales load

What to watch

  • Expensive for its category (1.81%)
  • 12b-1 marketing fee of 1% a year

Updated Nov 19, 2026

What DCUCX invests in

The fund seeks long-term growth of capital.

Main investments. Under normal circumstances, the fund invests at least 80% of net assets, plus the amount of any borrowings for investment purposes, in common stocks issued by US companies. Companies are selected for the funds portfolio using the Cash Return on Capital Invested (CROCI ) strategy as the primary factor, among other factors. Portfolio management will select stocks from among the largest US companies which are under CROCI coverage at any given time (the number of companies under CROCI coverage will vary; as of December 31, 2025, approximately 850 companies were under CROCI coverage, including approximately 370 US companies). Companies are identified from the selection universe for investment and are selected from the following economic sectors classified in accordance with the Global Industry Classification Standard (GICS): Consumer Discretionary, Consumer Staples…

From the fund's prospectus (filed Jan 27, 2026).

What DCUCX costs

On a $10,000 investment, DCUCX's 1.81% expense ratio costs about $181 a year. The prospectus estimates $1,975 in total costs over 10 years (assuming 5% annual returns). The median large blend fund charges 0.83%.

See the full DCUCX fee table →

DCUCX top 10 holdings

#Holding% of fund
1Micron Technology Inc6.88%
2Alphabet Inc3.32%
3Kraft Heinz Co/The3.16%
4Bristol-Myers Squibb Co3.11%
5Merck & Co Inc2.97%
6Synchrony Financial2.45%
7Pfizer Inc2.40%
8JPMorgan Chase & Co2.37%
9Dell Technologies Inc2.35%
10Cognizant Technology Solutions Corp2.21%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 31.2% of the fund. See all top 25 holdings and asset mix →

Alternatives to DCUCX

More funds like DCUCX →

DCUCX FAQ

What is the expense ratio of DCUCX?
DCUCX's expense ratio is 1.81%, which works out to about $181 a year for every $10,000 invested. The prospectus estimates total costs of $1,975 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is DCUCX a good investment?
It depends on your goals, but the data points to: no front-end sales load; expensive for its category (1.81%); 12b-1 marketing fee of 1% a year. This is general information, not personalized advice.
What does DCUCX hold?
DCUCX's largest holdings are Micron Technology Inc (6.9%), Alphabet Inc (3.3%), Kraft Heinz Co/The (3.2%), Bristol-Myers Squibb Co (3.1%), Merck & Co Inc (3.0%). It holds 89 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
Does DCUCX have a sales load?
No. DCUCX has no front-end sales charge. It may charge a deferred sales charge of up to 1% if sold early.
Who manages DCUCX?
DCUCX is offered by DWS (Xtrackers) through Deutsche Dws Investment Trust.